摘要
Organoid-based strategies offer unique advantages for bone regeneration by recapitulating the multicellular architecture and dynamic microenvironment of native tissue. However, their clinical translation remains constrained by reliance on immunogenic, animal-derived matrices and limited immunomodulatory capacity. We propose a non-immunogenic, xeno-free, and cytokine-free plant-derived bioink composed of aloe vera gel, laponite nanoclay, and gelatin methacrylate (GelMA) for constructing immune-instructive bone organoids. This bioink enables long-term reprogramming of macrophages toward an M2 phenotype without exogenous cytokines, establishing a stable pro-regenerative immune microenvironment that enhances mesenchymal stem cell osteogenesis and extracellular matrix (ECM) maturation. The construct supports robust 3D tissue organization, immune-guided osteoinduction, and functional integration in vivo . Notably, this is the first demonstration of a plant-based bioink platform for organoid bioengineering, offering a scalable and translationally viable alternative to Matrigels. Our strategy redefines osteoimmunomodulatory material design and establishes immune-responsive bone organoids as a next-generation solution for large bone defect repair.
危险品化学品经营许可证(带存储)